Notice of Meeting, 38869 [2023-12675]

Download as PDF Federal Register / Vol. 88, No. 114 / Wednesday, June 14, 2023 / Notices 38869 POPULATION, INTERVENTION, COMPARATOR, OUTCOME, TIMING, SETTING/STUDY DESIGN (PICOTS)—Continued Element Inclusion Exclusion Study design KQ1–3 ............ • Randomized controlled trials (RCTs) .......................... • Non-randomized controlled trials, including quasi-experimental and controlled before-and-after studies. • Prospective cohort studies with or without comparison group with appropriate analytic technique. • Nested case-control studies. ....................................... • Narrative reviews. • Systematic reviews, meta-analyses, umbrella reviews, scoping reviews. • Systematic reviews or meta-analyses that exclusively include cross-sectional and/or uncontrolled studies. • Retrospective cohort studies. • All other study designs. Language KQ1–3 ................. Geographic Location KQ1–3 Study size KQ1–3 ................ English only (due to resource limitations) ....................... Locations with food products or dietary supplements widely available to U.S. consumers, including those rated very high on the Human Development Index. .......................................................................................... Publication date KQ1–3 ....... Publication status KQ1–3 .... 2000 to present. Articles published in peer-reviewed journals .................. Studies with N < 50 participants (for RCTs—25 participants analyzed per study arm), and without power calculation. Articles that have not been peer reviewed and are not published in peer-reviewed journals (e.g., unpublished data, manuscripts, pre-prints, reports, abstracts, conference proceedings). Abbreviations: AMDR = Acceptable macronutrient distribution range; GI = gastrointestinal; U.S. = United States; KQ = key question; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; RCT = randomized controlled trial. Dated: June 8, 2023. Marquita Cullom, Associate Director. [FR Doc. 2023–12678 Filed 6–13–23; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice. AGENCY: The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel (SEP) meeting on ‘‘Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, PersonCentered Care to People with Long COVID (U18).’’ This SEP meeting will be closed to the public. DATES: July 27–28, 2023. ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427–1557. SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of experts in fields related to health care research ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:24 Jun 13, 2023 Jkt 259001 who are invited by AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in a particular review meeting which requires their type of expertise. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for ‘‘Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, PersonCentered Care to People with Long COVID (U18)’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for this meeting are subject to change as priorities dictate. Dated: June 8, 2023. Marquita Cullom, Associate Director. [FR Doc. 2023–12675 Filed 6–13–23; 8:45 am] BILLING CODE 4160–90–P PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC Town Hall Meeting Concerning Future Directions for the Regional Centers for Public Health Preparedness and Response Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces a town hall meeting regarding the history and future of CDC-funded public health preparedness and response centers. DATES: The town hall meeting will be held on Wednesday, June 28, 2023, from 1 p.m. to 5 p.m. EDT. ADDRESSES: The town hall meeting is a virtual meeting and is open to the public, limited only by the webcast lines available. Registration is required. For information about accessing the webcast, visit https://www.cdc.gov/orr/ science/research.htm. FOR FURTHER INFORMATION CONTACT: Mary Leinhos, Ph.D., Office of Readiness and Response, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21–5, Atlanta, Georgia 30329–4018; Phone: (770) 488–8619; Email: CPROAR@ CDC.gov. SUPPLEMENTARY INFORMATION: Purpose: The purpose of this town hall meeting is to provide an overview SUMMARY: E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 88, Number 114 (Wednesday, June 14, 2023)]
[Notices]
[Page 38869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12675]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) 
announces a Special Emphasis Panel (SEP) meeting on ``Implementing and 
Evaluating New Models for Delivering Comprehensive, Coordinated, 
Person-Centered Care to People with Long COVID (U18).'' This SEP 
meeting will be closed to the public.

DATES: July 27-28, 2023.

ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted 
Review), 5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 
Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427-1557.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the Panel do not attend regularly scheduled meetings and do not 
serve for fixed terms or a long period of time. Rather, they are asked 
to participate in a particular review meeting which requires their type 
of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 
552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for 
``Implementing and Evaluating New Models for Delivering Comprehensive, 
Coordinated, Person-Centered Care to People with Long COVID (U18)'' are 
to be reviewed and discussed at this meeting. The grant applications 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: June 8, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-12675 Filed 6-13-23; 8:45 am]
BILLING CODE 4160-90-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.